News & Updates
Filter by Specialty:
Inferior vena cava filters safely reduce pulmonary embolism risk in VTE
08 Dec 2021
The use of inferior vena cava filters appears to effectively reduce the risk of pulmonary embolism (PE) and PE-related and all-cause deaths in patients with venous thromboembolism (VTE), reports a recent meta-analysis.
Inferior vena cava filters safely reduce pulmonary embolism risk in VTE
08 Dec 2021Short-course, high-dose gatifloxacin gets a pass in multidrug-resistant TB with caveat
08 Dec 2021
byJairia Dela Cruz
A short-term treatment regimen based on high-dose gatifloxacin appears to be effective against multidrug- or rifampicin-resistant tuberculosis (TB) but at the cost of increased severe adverse drug reactions, as shown in a study.
Short-course, high-dose gatifloxacin gets a pass in multidrug-resistant TB with caveat
08 Dec 2021Ixekizumab effective for difficult-to-treat psoriatic arthritis
08 Dec 2021
byAudrey Abella
The monoclonal antibody ixekizumab improved the signs and symptoms of psoriatic arthritis (PsA) in PsA patients with inadequate response to one or two tumour necrosis factor inhibitors (TNFis), suggests results from a post hoc subanalysis of the SPIRIT-P2 trial.